Redmile Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.1M | Sell |
|
|||||
|
2025
Q1 | $26.9M | Sell |
|
|||||
|
2024
Q4 | $44.3M | Sell |
|
|||||
|
2024
Q3 | $65.9M | Sell |
|
|||||
|
2024
Q2 | $47.1M | Sell |
|
|||||
|
2024
Q1 | $69.7M | Sell |
|
|||||
|
2023
Q4 | $46.4M | Sell |
|
|||||
|
2023
Q3 | $26M | Hold |
|
|||||
|
2023
Q2 | $43M | Sell |
|
|||||
|
2023
Q1 | $71.4M | Sell |
|
|||||
|
2022
Q4 | $66.7M | Sell |
|
|||||
|
2022
Q3 | $62.6M | Buy |
|
|||||
|
2022
Q2 | $51.3M | Sell |
|
|||||
|
2022
Q1 | $111M | Buy |
|
|||||
|
2021
Q4 | $164M | Sell |
|
|||||
|
2021
Q3 | $164M | Buy |
|
|||||
|
2021
Q2 | $123M | Sell |
|
|||||
|
2021
Q1 | $101M | Sell |
|
|||||
|
2020
Q4 | $169M | Sell |
|
|||||
|
2020
Q3 | $88.3M | Buy |
|